Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly, Wegovy and Zepbound
Tirzepatide Tops Semaglutide for Weight Loss in Head-to-Head Trial, Eli Lilly Says
Adults on the obesity medication tirzepatide (Zepbound) lost more weight on average than those on semaglutide (Wegovy) in a head-to-head trial of the two injectables, Eli Lilly announced on Wednesday.
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly.
Eli Lilly's Zepbound Tops Novo Nordisk's Wegovy in Weight-Loss Trial
Eli Lilly's popular weight-loss drug Zepbound outperformed Danish drugmaker Novo Nordisk's Wegovy in a clinical trial, according results of the study released Wednesday.
Eli Lilly, Obesity
Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand
Eli Lilly LLY recently announced its plans to spend $3 billion to expand the manufacturing facility in Wisconsin that was acquired earlier this year from Nexus Pharmaceuticals. Management expects to start construction on this expansion next year.
U.K. to restrict Eli Lilly’s obesity drug to patients with greatest need
The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible, and alongside a specialized diet.
Eli Lilly’s Obesity Drug Set for Slow NHS Rollout in England
England’s National Health Service will begin rolling out Eli Lilly & Co.’s blockbuster weight-loss drug Mounjaro over the next few months, though the medication will initially be made available to only a small proportion of the patients who could benefit from it.
BioSpace
5h
Lilly Pumps $3B Into Wisconsin Site as Compounders Close in on Tirzepatide
Eli Lilly is aggressively ramping up its manufacturing capacity for tirzepatide as compounding pharmacies continue to ...
Seeking Alpha on MSN
22h
Lilly's Zepbound will first be given in the UK to those with 'highest clinical need'
Given the strong demand expected for
Eli
Lilly
's (NYSE:LLY) weight loss treatment Zepbound (
tirzepatide
) in the UK, the ...
23h
Eli Lilly to spend $3 billion, add 750 employees in Kenosha County expansion
Drugmaker Eli Lilly and Co. will invest $3 billion and add 750 employees in Kenosha County as the company expands a plant it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
US adds 227,000 jobs
Massive fire in Baltimore
‘One Life to Live’ star dies
Biden considers pardons
Wild bird lays egg at 74
Hit six months in space
'Patriot of the Year' award
Ethics report release blocked
Several prisons to be closed
Set to return after 20 years
White Sox legend dies
To be ambassador to China
Scott tapped to lead CBP
Promotes trade w/ Mexico
Jury deliberations continue
Syrian rebels advance
Iran: Space launch successful
Prenatal test spots cancer?
Sacks to lead AI, crypto
New AI tools for employees
Satellites to create eclipses
Delays oil output hike
Airbus layoffs
Moon missions delayed
Meet with lawmakers
Pledges hit $100 billion
Joins X Games as CEO
Judge rejects plea deal
Blackhawks fire coach
Appeals court upholds ban
NBA returning to China
Feedback